Telemetry Investments’s Immune Design Corp. IMDZ Stock Holding History

Telemetry Investments’s Portfolio IMDZ Stock Details IMDZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-79,555	Closed	-$274K	–	173
2018 Q3	$274K	Sell	79,555 -33,945	-30%	-$127K	0.12%	84
2018 Q2	$516K	Sell	113,500 -135,300	-54%	-$539K	0.2%	57
2018 Q1	$821K	Buy	248,800 +209,505	+533%	+$742K	0.31%	57
2017 Q4	$153K	Buy	+39,295	New	+$214K	0.06%	122

Other funds holding IMDZ

Peter Svennilson $1.23B AUM 301.34% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

VVM

Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BCPEM

Bain Capital Public Equity Management Boston, Massachusetts $1.05B AUM 25.71% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Telemetry Investments's IMDZ Position: Q4 2018 in Review

Telemetry Investments sold out of Immune Design Corp. (IMDZ) in Q4 2018, closing a stake of 79,555 shares — an estimated $274K sold.

Telemetry Investments first reported a position in IMDZ in Q4 2017 and held it in 4 quarters. The position peaked at $821K in Q1 2018. 64 funds tracked by Wall St. Rank hold IMDZ as of Q4 2018.

Telemetry Investments reported no remaining Immune Design Corp. position as of Q4 2018 after selling out during the quarter.
Telemetry Investments sold 79,555 Immune Design Corp. shares in Q4 2018, an estimated $274K.
Telemetry Investments first reported a position in Immune Design Corp. in Q4 2017 and held it in 4 quarters.
Telemetry Investments's Immune Design Corp. position peaked at $821K in Q1 2018.
64 funds tracked by Wall St. Rank held Immune Design Corp. as of Q4 2018.

Based on Telemetry Investments's 13F filing for Q4 2018, filed 14 Feb 2019.